Article

January is Glaucoma Awareness Month

January is National Glaucoma Awareness Month, and in observance, the four principal investigators of the Glaucoma Research Foundation (GRF) Catalyst for a Cure consortium will present a scientific overview of recent research advances.

San Francisco

-January is National Glaucoma Awareness Month, and in observance, the four principal investigators of the Glaucoma Research Foundation (GRF) Catalyst for a Cure consortium will present a scientific overview of recent research advances as part of the organization’s benefit Jan. 28 at the Palace Hotel in San Francisco. The event also will celebrate the group’s 31st anniversary.

“Early detection and treatment is the only way to prevent further vision loss” associated with the disease, said Thomas M. Brunner, GRF president and chief executive officer. “At GRF, we believe that a cure is attainable in the future, and National Glaucoma Awareness Month helps us raise awareness for potential treatments and cures available to glaucoma patients today.”

For more information about the event, contact Craig Palmer at 415/986-3162 or

cpalmer@glaucoma.org

.

Founded in 1978 in San Francisco, the GRF claims to be the oldest national foundation dedicated to preventing vision loss from glaucoma. The organization invests in research, education, and support with the ultimate goal of finding a cure.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) Inside NYEE’s new refractive solutions center with Kira Manusis, MD
(Image credit: Ophthalmology Times) Dilsher Dhoot, MD, on the evolution of geographic atrophy therapy: where are we now?
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
(Image credit: Ophthalmology Times) Two-wavelength autofluorescence for macular xanthophyll carotenoids with Christine Curcio, PhD
(Image credit: Ophthalmology Times) FLIO and the brain: Making the invisible visible with Robert Sergott, MD
(Image credit: Ophthalmology Times) Structure-function correlates using high-res OCT images with Karl Csaky, MD, PhD
(Image credit: Ophthalmology Times) SriniVas Sadda, MD, on high-res OCT of atrophic and precursor lesions in AMD
(Image credit: Ophthalmology Times) Christine Curcio, PhD, shares histology update supporting review software and revised nomenclature for <3 μm OCT
1 expert is featured in this series.
© 2025 MJH Life Sciences

All rights reserved.